Skip to content

Moderna MRNA Inventories

Inventories at other companies

Pfizer logo
PfizerPFE
$2.46B-11.9%
Novavax logo
NovavaxNVAX
$11.46M+11.6%
ALN
Alnylam PharmaceuticalsALNY
$19.9M-72.2%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$55M+19.5%
Gilead Sciences logo
Gilead SciencesGILD
$2.42B+20.1%

Other financials

Income statement

See full
Revenue$389.0M+260%
Gross profit-$566.0M-3,244%
Operating income-$1.4B-32.2%
Net income-$1.3B-38.3%
EPS (diluted)-$3.40-34.9%

Balance sheet

See full
Cash & equivalents$1.9B+17.4%
Total debt$1.3B+71.9%
Total equity$7.4B-26.4%
Total assets$11.5B-9.6%

Cash flow

See full
Operating cash flow-$630.0M+39.2%
CapEx$62.0M-47.0%
Free cash flow-$692.0M+40.0%

Valuation

See full
Market cap$21.62B+73.9%
Enterprise value$21.04B+76.5%
P/S9.7×+5.7×

Profitability

See full
Gross margin22.1%-32.0pp
Operating margin-153.3%+67.8pp
Net margin-143.6%+80.2pp
FCF margin-132.4%

Returns & leverage

See full
Return on equity-36.6%+11.9pp
Debt / equity0.2×+0.1×
Current ratio2.4×-1.8×

Where this comes from

Reported directly by Moderna in its filing.

Tagged under the XBRL concept us-gaap:InventoryNoncurrent.

The official record: Moderna’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Moderna's inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Moderna's inventories?
Moderna (MRNA) reported inventories of $117M in Q1 2026.
How has Moderna's inventories changed year-over-year?
Moderna's inventories decreased by 12.7% year-over-year, from $134M to $117M.
What is the long-term trend for Moderna's inventories?
Over 4 years (2021 to 2025), Moderna's inventories has grown at a -39.0% compound annual growth rate (CAGR), from $3.54B to $490M.
What does inventories mean?
Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.